Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • For a short-term investment strategy, the company has poor fundamentals.
Strengths
  • The group's high margin levels account for strong profits.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 81.74 USD
Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
  • The stock is close to a major daily resistance at USD 98, which should be gotten rid of so as to gain new appreciation potential.
  • The group usually releases earnings worse than estimated.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • With an expected P/E ratio at 59.01 and 36.57 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company is not the most generous with respect to shareholders' compensation.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart
Sector Medical Equipment
1st jan.Capitalisation (M$)Investor Rating
ABBOTT LABORATORIES7.08%164 520
MASIMO CORPORATION49.91%12 998
ASAHI INTECC CO., LTD.2.81%7 983
NOVOCURE LIMITED-21.31%6 773
GETINGE AB-0.14%5 021
JIANGSU YUYUE MEDICAL EQUIP..57.48%4 371
SHOCKWAVE MEDICAL, INC.0.91%1 402
TACTILE SYSTEMS TECHNOLOGY,..-26.62%932
SI-BONE, INC.-14.14%497
SEMLER SCIENTIFIC, INC.-11.90%276
I-SENS INC--.--%270
-
MISONIX, INC.-28.48%242
DAIKEN MEDICAL CO., LTD.-6.31%169
APOLLO ENDOSURGERY, INC.-37.19%38
ELECTROCORE, INC.-42.26%35
INSPIRATION HEALTHCARE GROU..-1.49%32
More Results
Financials (USD)
Sales 2020 31 318 M - -
Net income 2020 2 774 M - -
Net Debt 2020 11 897 M - -
P/E ratio 2020 57,8x
Yield 2020 1,55%
Capitalization 165 B 165 B -
EV / Sales 2019
EV / Sales 2020 5,63x
Nbr of Employees 107 000
Free-Float 88,8%
Upcoming event on ABBOTT LABORATORIES
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes